179 related articles for article (PubMed ID: 6292827)
1. Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes.
Castro-Malaspina H; Moore MA
Nouv Rev Fr Hematol (1978); 1982; 24(4):221-6. PubMed ID: 6292827
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components.
Castro-Malaspina H
Prog Clin Biol Res; 1984; 154():427-54. PubMed ID: 6089232
[TBL] [Abstract][Full Text] [Related]
3. Properties of myelofibrosis-derived fibroblasts.
Castro-Malaspina H; Jhanwar SC
Prog Clin Biol Res; 1984; 154():307-22. PubMed ID: 6382300
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia.
Muth M; Engelhardt BM; Kröger N; Hussein K; Schlué J; Büsche G; Kreipe HH; Bock O
Ann Hematol; 2011 Jan; 90(1):33-40. PubMed ID: 20625903
[TBL] [Abstract][Full Text] [Related]
5. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of myelofibrosis with myeloid metaplasia.
Tefferi A
J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
8. Myelofibrosis: experimental models and human studies.
Taskin AL; Cohen-Solal K; Le Couedic JP; Abina MA; Villeval JL; Debili N; Casadevall N; Vainchenker W; Wendling F
Stem Cells; 1998; 16 Suppl 2():155-64. PubMed ID: 11012187
[TBL] [Abstract][Full Text] [Related]
9. [Beneficial effect of 1,25-dihydroxyvitamin D3 in the treatment of myelofibrosis].
Palomera L; García Díez I; Martínez R
Med Clin (Barc); 1989 Sep; 93(7):265-8. PubMed ID: 2811498
[TBL] [Abstract][Full Text] [Related]
10. Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis.
Ciaffoni F; Cassella E; Varricchio L; Massa M; Barosi G; Migliaccio AR
Blood Cells Mol Dis; 2015 Mar; 54(3):234-41. PubMed ID: 25703685
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines.
Bock O; Höftmann J; Theophile K; Hussein K; Wiese B; Schlué J; Kreipe H
Am J Pathol; 2008 Apr; 172(4):951-60. PubMed ID: 18349123
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic implications of collagen metabolism in myelofibrosis.
Fruchtman SM
Prog Clin Biol Res; 1984; 154():467-74. PubMed ID: 6382307
[TBL] [Abstract][Full Text] [Related]
13. [TGF-beta and platelet].
Kogawa K; Mogi Y; Morii K; Takimoto R; Niitsu Y
Rinsho Ketsueki; 1994 Apr; 35(4):370-5. PubMed ID: 8028182
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Hilgarth M; Hubmann R; Duechler M; Gisslinger H
J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
[TBL] [Abstract][Full Text] [Related]
15. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructure of bone marrow tissue in so-called primary (idiopathic) myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia). I. Abnormalities of megakaryopoiesis and thrombocytes.
Thiele J; Kuemmel T; Sander C; Fischer R
J Submicrosc Cytol Pathol; 1991 Jan; 23(1):93-107. PubMed ID: 2036630
[TBL] [Abstract][Full Text] [Related]
17. Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis.
Florena AM; Tripodo C; Di Bernardo A; Iannitto E; Guarnotta C; Porcasi R; Ingrao S; Abbadessa V; Franco V
J Clin Pathol; 2009 Apr; 62(4):331-8. PubMed ID: 19329711
[TBL] [Abstract][Full Text] [Related]
18. Acute myelofibrosis--a leukemia of pluripotent stem cell. A report of three cases and review of the literature.
Amberger DM; Saleem A; Kemp BL; Truong LD
Ann Clin Lab Sci; 1990; 20(6):409-14. PubMed ID: 2073090
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
20. [Current views on the pathogenesis and treatment of spontaneous (primary) myelofibrosis].
Robak T
Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):144-7. PubMed ID: 1437804
[No Abstract] [Full Text] [Related]
[Next] [New Search]
